Volume 87 Issue 27 | p. 14 | Concentrates
Issue Date: July 6, 2009

Sanofi Revamps R&D

Department: Business
Keywords: Sanofi-Aventis, R&D, Pharmaceutical

Pharmaceutical giant Sanofi-Aventis is rearranging its R&D infrastructure, particularly in its home country of France. Research head Marc Cluzel says the company wants to take a more entrepreneurial approach to research and increase its use of outside partners. Although the moves won’t involve outright layoffs, Sanofi says, about 300 people will be affected when sites in Bagneux, Rueil-Malmaison, and Evry, France, are closed and operations move to Chilly-Mazarin. Sanofi says it may divest its Porcheville site, where about 200 people are employed. And some sites in the U.S., U.K., Spain, and Japan will be sold or repurposed.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment